# Top 10 Life Science Angel Investors in Spain in June 2026

## David Brandes
- Type: Angel
- Location: Berlin, Berlin, Germany
- Relevant deals: 1
- Stages: Seed
- Focus: Wellness, Life Science, Biotechnology

David Brandes - Managing Director & Co-Founder @ Peace of Meat

## Arnaldo Marziali
- Type: Angel
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Big Data, Software, Life Science

Arnaldo Marziali

## Mariliis Holm
- Type: Angel
- Location: Research Triangle, North Carolina, United States
- Relevant deals: 1
- Stages: Pre-Seed, Angel
- Focus: Food Processing, Seafood, Wellness

I am a food scientist, entrepreneur and investor.
Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.

## Arturo Elizondo
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Wellness, Life Science, Biotechnology

Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.

## Milad Alucozai
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Biotechnology, Health Care, Medical

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

## Arman Anatürk
- Type: Angel
- Location: Lausanne, Vaud, Switzerland
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Food and Beverage, Wellness

Arman Anatürk is Co-Founder @ FoodHack.

## Ryan Bethencourt
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Pre-Seed, Seed, Angel
- Focus: Biotechnology, Food Processing, Food and Beverage

Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.

## Ritu Bansal-Mutalik
- Type: Angel
- Location: San Francisco Bay Area, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Wellness, Life Science, Biotechnology

Ritu Bansal-Mutalik is a Senior Director, Process Research and Development at ZymoChem.

## Inaki Berenguer
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: FinTech, E-Commerce, Financial Services

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

## John Bethell
- Type: Angel
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 1
- Stages: Debt Financing
- Focus: FinTech, Medical, Life Science

Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co